"Unsere Champions" acquired, for the first time, various childcare facilities in the German-speaking part of Switzerland from private sellers.
Basel-based MTIP, a private equity firm focusing on digital health and connected medical device companies, has completed a first closing of EUR 130m...
The Swiss-based start-up medical technology company STIMIT AG was founded in 2018...
Loomis, a Sweden-based and listed provider of cash handling services for banks, retailers and other commercial clients, has entered into an agreement to acquire certain assets and liabilities of SecurePost AG.
VISCHER has advised Wipro Limited, a leading global information technology, consulting and business process services company, on all Swiss legal aspects of the USD 1.45bn acquisition of Capco, spanning from due diligence to transactional document advice.
RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief") has entered into a binding agreement with a single healthcare-dedicated U.S. institutional investor to purchase in a private placement Relief shares of CHF 10m.
Trustar Capital (formerly known as CITIC Capital Partners), a private equity affiliate of CITIC Capital Holdings Limited, has completed its over USD 50.0m investment in the Switzerland based global leading medical technology company MedAlliance SA ("MedAlliance"), becoming MedAlliance's single largest shareholder.
Group companies of Vink Holdings Ltd. (Vink), the largest European distributor of plastic shapes, have taken over all distribution activities of MCAM in Poland and Hungary by buying the Polish distribution company and all Hungarian distribution activities from group companies of Mitsubishi Chemical Advanced Materials AG, a leading global manufacturer of high-performance thermoplastic materials in the form of semi-finished products and finished parts.
Capricorn Holding AG, which includes GEISER agro.com ag, active in the table fruit sector, agroSmart ag, as well as stakes in Terralog ag and vs.fruits sa, is one of the largest independent table fruit and potato logistics...
On January 13, 2021, Numab Therapeutics AG (Wädenswil, Switzerland) entered into a global co-development and regional licensing agreement with Kaken Pharmaceutical Co., Ltd. (Tokyo, Japan) for Numab's novel multispecific anti-inflammatory drug candidate NM26- 2198, which blocks three key pathways in the pathophysiology of atopic dermatitis.